[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368651-105":59,"doc-detail-368651-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ufmylation-maintains-tumor-suppressor-pvhl-stability-by-activating-the-deubiquitinase-bap1","UFMylation maintains tumor suppressor pVHL stability by activating the deubiquitinase BAP1","","BRCA1-associated protein 1 (BAP1) can act as a tumor suppressor or oncogene, yet its mechanism in colorectal cancer (CRC) remains unclear. This study shows BAP1 suppresses CRC progression by deubiquitinating and stabilizing von Hippel–Lindau tumor suppressor protein (pVHL). BAP1 is UFMylated by UFM1 at multiple lysines, strengthening pVHL binding and preserving pVHL levels. Loss of UFMylation, via UFL1 depletion or a 4KR mutant, increases tumor progression in CRC models.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ufmylation-maintains-tumor-suppressor-pvhl-stability-by-activating-the-deubiquitinase-bap1/368651/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ufmylation-maintains-tumor-suppressor-pvhl-stability-by-activating-the-deubiquitinase-bap1/368651.png","ImageObject",300,407,{"name":92,"@type":93},"Chumphorn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What mechanism links BAP1 to suppression of colorectal cancer progression?","Question",{"text":112,"@type":113},"BAP1 suppresses CRC progression by deubiquitinating and stabilizing pVHL, thereby maintaining its tumor-suppressive function.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does UFMylation affect BAP1 activity?",{"text":117,"@type":113},"UFMylation by UFM1 at specific lysines enhances BAP1’s interaction with pVHL and promotes pVHL stabilization.",{"name":119,"@type":110,"acceptedAnswer":120},"What happens to pVHL and tumor progression when UFMylation is lost?",{"text":121,"@type":113},"UFL1 depletion or using a UFMylation-defective BAP1 mutant (4KR) impairs pVHL stabilization and promotes tumor progression in CRC cell line–based and patient-derived xenograft models.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368651,1790391737,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},2336475401981,"https://ap-avatar.wpscdn.com/avatar/22000c94efd8d5204d?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786935347598174694","CANCER  \nUFMylation maintains tumor suppressor pVHL stability by activating the deubiquitinase BAP1  \nXiao Yang1†, Yalei Wen2†, Shengying Qin3,4†, Yang Zhou1†, Caishi Zhang1, Lei Huang1, Mei Li1, Xiuqing Ma1, Rui Wan1, Jiaqi Chen1, Rong-Rong He1,5,6, Hao Gao6, Colin R. Goding7,  \nOscar Junhong Luo8*, Xiangchun Shen9*, Rutao Cui10*, Tongzheng Liu1,9*  \nBRCA1-associated protein 1 (BAP1) can function as a tumor suppressor or oncogene depending on context, but its role in colorectal cancer (CRC) is not well understood. Here, we demonstrate that BAP1 suppresses CRC progression primarily by deubiquitinating and stabilizing von Hippel–Lindau tumor suppressor protein (pVHL). BAP1 undergoes covalent modification by ubiquitin-fold modifier 1 (UFM1) at Lys51, Lys61, Lys187, and Lys205, enhancing its interaction with pVHL and promoting pVHL stabilization. Loss of this modification through UFL1 depletion or reconstitution with a UFMylation-defective BAP1 mutant (4KR) impairs pVHL stabilization and promotes tumor progression in CRC cell line–based and patient-derived xenograft models. Clinically, down-regulation of UFL1 and BAP1 correlates with reduced pVHL level and poor prognosis in patients with CRC. These findings identify a previously unrecognized posttranslational mechanism regulating BAP1 activity and highlight UFMylation as essential for maintaining pVHL tumor-suppressive function. Targeting BAP1 UFMylation may represent a potential therapeutic strategy in CRC and other cancers with wild-type BAP1 and VHL.  \ncopyright © 2025 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. distributed under a creative commons Attribution noncommercial license 4.0 (cc BY-nc) .  \nINTRODUCTION  \nColorectal cancer (CRC) is one of the most prevalent cancers and a leading cause of cancer-related death worldwide (1). Despite advancements in early diagnosis and systemic therapies for CRC, the prognosis for advanced CRC remains poor, with a dismal 5-year survival rate due to metastasis and resistance to existing therapies (2). Thus, to elucidate the key mechanisms driving CRC progression and to identify potential therapeutic targets are urgently needed.  \nRecent evidence suggests that the role ofBRCA1-associated protein 1 (BAP1) in cancer is highly context dependent, varying across cell types. Frequent mutations or deletions in the BAP1 gene are associated with a high incidence of malignant mesothelioma, clear cell renal cell carcinoma (ccRCC), and uveal melanoma (3–5) . In murine models, heterozygous loss of BAP1 in the pancreas causes pancreatitis and, in combination with KrasG12D expression, leads to rapid progression to metastatic pancreatic cancer, suggesting that BAP1 acts as a  \n1State Key laboratory of Bioactive Molecules and druggability Assessment/ international cooperative laboratory of traditional chinese Medicine Modernization and innovative drug development of Ministry of education (MOe) of china/college of Pharmacy, Jinan University, Guangzhou 510632, china. 2Guangdong Second Provincial General hospital, Postdoctoral Station of traditional chinese Medicine, School of Medicine, Jinan University, Guangzhou 510632, china. 3department of Oncology, the First Affiliated hospital of Jinan University, Guangzhou 510630, china. 4clinical Medical Research institute, Jinan University, Guangzhou 510630, china. 5Guangdong engineering Research center of chinese Medicine and disease Susceptibility, Jinan University, Guangzhou 510632 china. 6institute of traditional chinese Medicine and natural Products, college of Pharmacy/State Key laboratory of Bioactive Molecules and druggability Assessment/international cooperative laboratory of traditional chinese Medicine Modernization and innovative drug development of Ministry of education (MOe) of china/Guangdong Province Key laboratory of Pharmacodynamic constituents oftcM and new drugs Research, Jinan University,","cbCaivCGakRXK2Lz","https://ap.wps.com/l/cbCaivCGakRXK2Lz","pdf",14353703,16,"English","# INTRODUCTION","[{\"question\":\"What mechanism links BAP1 to suppression of colorectal cancer progression?\",\"answer\":\"BAP1 suppresses CRC progression by deubiquitinating and stabilizing pVHL, thereby maintaining its tumor-suppressive function.\"},{\"question\":\"How does UFMylation affect BAP1 activity?\",\"answer\":\"UFMylation by UFM1 at specific lysines enhances BAP1’s interaction with pVHL and promotes pVHL stabilization.\"},{\"question\":\"What happens to pVHL and tumor progression when UFMylation is lost?\",\"answer\":\"UFL1 depletion or using a UFMylation-defective BAP1 mutant (4KR) impairs pVHL stabilization and promotes tumor progression in CRC cell line–based and patient-derived xenograft models.\"}]","UFMylation maintains tumor suppressor pVHL stability by activating the deubiquitinase BAP1 | PDF",1790177860,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a01ce81f45806bad7e59f55595eff12.webp",983,1250,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7dff0ea1d99064c5c44c4636079432f.webp",982,1249,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a02fcfe1943e65e080a5be2755637e9f.webp",981,1248,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07a6376ed3cc5c51e8b596676ead137b.webp",980,1247]